Gerfried Pesau

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

MiR-182-5p, miR-122-5p and hsa-piR-28004 as indicators of disease and treatment in pediatric familial hypercholesterolemia.

MiR-182-5p, miR-122-5p and hsa-piR-28004 as indicators of disease and treatment in pediatric familial hypercholesterolemia.

Journal: Pediatric research

Published: August 20, 2025

Prevalence of extracranial carotid artery disease in symptomatic peripheral artery disease and implications for long-term outcome.

Prevalence of extracranial carotid artery disease in symptomatic peripheral artery disease and implications for long-term outcome.

Journal: Annals of medicine

Published: March 13, 2025

Letter: Answer to "Trefoil Factor-3 and Peripheral Artery Disease: Reason or Result".

Letter: Answer to "Trefoil Factor-3 and Peripheral Artery Disease: Reason or Result".

Journal: Angiology

Published: August 26, 2024

Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease.

Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease.

Journal: Angiology

Published: February 05, 2024

Galectin-3 is linked to peripheral artery disease severity, and urinary excretion is associated with long-term mortality.

Galectin-3 is linked to peripheral artery disease severity, and urinary excretion is associated with long-term mortality.

Journal: Atherosclerosis

Published: July 28, 2021

Angiogenin-A Proposed Biomarker for Cardiovascular Disease-Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease.

Angiogenin-A Proposed Biomarker for Cardiovascular Disease-Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease.

Journal: Angiology

Published: March 29, 2021

GlycA for long-term outcome in T2DM secondary prevention.

GlycA for long-term outcome in T2DM secondary prevention.

Journal: Diabetes research and clinical practice

Published: September 28, 2020

Evaluation of sCD163 and sTWEAK in patients with stable peripheral arterial disease and association with disease severity as well as long-term mortality.

Evaluation of sCD163 and sTWEAK in patients with stable peripheral arterial disease and association with disease severity as well as long-term mortality.

Journal: Atherosclerosis

Published: July 07, 2020

Predictive power of novel and established obesity indices for outcome in PAD during a five-year follow-up.

Predictive power of novel and established obesity indices for outcome in PAD during a five-year follow-up.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: November 17, 2019

sCD40L: An overestimated marker for cardiovascular risk prediction?

sCD40L: An overestimated marker for cardiovascular risk prediction?

Journal: Atherosclerosis

Published: October 03, 2019

Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes.

Thrombospondin-4 increases with the severity of peripheral arterial disease and is associated with diabetes.

Journal: Heart and vessels

Published: February 02, 2019

To the editor regarding article "Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study".

To the editor regarding article "Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study".

Journal: Diabetology & metabolic syndrome

Published: November 09, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026